XPA and prostate cancer: To assay the effect of XPA on ENZ-resistant prostate cancer cells in vivo, LNCaP/ENZ (1 × 106) expressing sgSCR or sgXPA were injected subcutaneously into the flanks of 8-week-old male castrated nude mice (Fig. 6A).